T-CELL LYMPHOMA
Clinical trials for T-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough leukemia: targeted drugs added to chemo
Disease control Recruiting nowThis study tests whether adding either dasatinib or venetoclax to standard chemotherapy can help more children with T-cell acute lymphoblastic leukemia or lymphoma achieve a deep remission. About 100 children and young adults aged 1 to 18 will receive one of these targeted drugs …
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 26, 2026 11:26 UTC
-
New drug combo aims to outsmart Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial tests a new drug called BI-1808, alone or with pembrolizumab, in people with advanced cancers (like ovarian cancer, melanoma, or T-cell lymphoma) that have not responded to standard therapy. The main goals are to check safety, find the best dose, and see if…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: BioInvent International AB • Aim: Disease control
Last updated May 26, 2026 11:25 UTC
-
New drug may prevent lymphoma relapse after transplant
Disease control Recruiting nowThis study tests whether the drug ruxolitinib can help prevent T-cell lymphoma from returning and reduce graft-versus-host disease (GVHD) after a stem cell transplant. About 44 adults with T-cell lymphoma who are in remission after transplant will take ruxolitinib as a maintenanc…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Jonathan Brammer • Aim: Disease control
Last updated May 26, 2026 11:22 UTC
-
New hope for rare blood cancer: targeted drug trial opens
Disease control Recruiting nowThis study tests a drug called enasidenib in people with a rare type of T-cell lymphoma (AITL) that has a specific genetic change (IDH2 mutation). The goal is to see if the drug is safe and effective when given alone or with another drug, rituximab. About 25 adults whose cancer h…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 26, 2026 11:18 UTC
-
New hope for tough lymphoma: experimental drug ST-001 enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called ST-001 (a form of fenretinide) in people with T-cell non-Hodgkin lymphoma whose cancer has returned or not responded to prior treatments. The main goal is to find the safest dose and understand side effects. About 46 participants wil…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated May 26, 2026 11:13 UTC
-
Engineered T-Cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis early-phase study tests a new treatment called CD4CAR for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, modified in a lab to target and attack cancer cells. The main goal is t…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Huda Salman • Aim: Disease control
Last updated May 26, 2026 11:08 UTC
-
New combo therapy targets tough-to-treat lymphoma
Disease control Recruiting nowThis study tests whether adding the drug mogamulizumab to standard chemotherapy can improve outcomes for people with aggressive T-cell lymphoma. About 22 adults with newly diagnosed or returning lymphoma will receive the combination treatment. The main goal is to see how many pat…
Matched conditions: T-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
Crushed pill study aims to help kids with blood cancer who Can't swallow tablets
Knowledge-focused Recruiting nowThis study looks at how the body processes venetoclax when the tablets are crushed and mixed into a liquid for children and young adults with blood cancers like leukemia or lymphoma. About 30 participants who already take venetoclax this way will have their blood levels measured.…
Matched conditions: T-CELL LYMPHOMA
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated May 26, 2026 11:16 UTC